On #WorldCancerDay, we want to highlight that, unfortunately, no one is “too young” for cancer. Since the 1990s, there has been a significant increase in colorectal, gastric, pancreatic, and biliary tract cancers among individuals younger than 50 years of age, highlighting the need for increased awareness and proactive health measures. It is crucial for everyone, regardless of age, to be aware of the symptoms, personal risks, and available screening options for the different types of digestive cancers. This understanding can save many lives! #UnitedByUnique To learn more about our work on this matter, visit➡️entero.digestivecancers.eu/e… @EU_Health @EU_ScienceHub @MAC_MEPs @EuObesity @MEPsDiab @IARCWHO @WorldCancerDay

At DiCE, we believe that expanded access to biosimilars is vital for ensuring patients receive timely, affordable, and effective treatments. By increasing access to these essential medicines, we can ensure better patient outcomes and ultimately improve their quality of life. However, barriers such as a lack of acceptability and awareness remain among the biggest challenges to advancing access to biosimilars. That’s why tomorrow, as we kick off #GlobalBiosimilarsWeek, we’ll be sharing 5⃣ key #myths and #facts about biosimilars to help debunk these common misunderstandings on this topic. We invite you to join us in raising awareness on this matter by visiting our biosimilars education page➡️biosimilars.education.digest… #GBW24 #biosimilars #biosimilar #BiosimilarsAccess #TogetherforBiosimilars #BiosimilarAccessTogether